Fortem Financial Group LLC Boosts Stock Holdings in GoodRx Holdings, Inc. (NASDAQ:GDRX)

Fortem Financial Group LLC lifted its position in shares of GoodRx Holdings, Inc. (NASDAQ:GDRX) by 7.2% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 119,179 shares of the company’s stock after purchasing an additional 7,996 shares during the period. Fortem Financial Group LLC’s holdings in GoodRx were worth $554,000 at the end of the most recent quarter.

Other large investors also recently made changes to their positions in the company. nVerses Capital LLC purchased a new stake in GoodRx in the 3rd quarter valued at about $33,000. Plato Investment Management Ltd purchased a new stake in shares of GoodRx during the second quarter valued at approximately $43,000. EP Wealth Advisors LLC bought a new stake in GoodRx during the third quarter worth $73,000. Dark Forest Capital Management LP bought a new stake in GoodRx during the second quarter worth $86,000. Finally, Sanctuary Advisors LLC purchased a new position in GoodRx in the third quarter worth $85,000. 63.77% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

GDRX has been the topic of a number of recent analyst reports. Morgan Stanley lowered their target price on GoodRx from $7.00 to $6.00 and set an “equal weight” rating on the stock in a research note on Tuesday, December 17th. Citigroup lowered their price objective on shares of GoodRx from $10.00 to $7.00 and set a “buy” rating on the stock in a research report on Wednesday, November 13th. Barclays reduced their target price on shares of GoodRx from $10.00 to $6.00 and set an “overweight” rating for the company in a research report on Monday, November 11th. Finally, Mizuho initiated coverage on shares of GoodRx in a report on Wednesday, December 4th. They issued a “neutral” rating and a $5.00 price target on the stock. Five analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $8.64.

GoodRx Price Performance

Shares of GDRX stock traded up $0.09 during trading hours on Monday, reaching $4.54. The stock had a trading volume of 1,324,533 shares, compared to its average volume of 1,339,287. The stock’s fifty day simple moving average is $4.90 and its 200 day simple moving average is $6.67. The firm has a market capitalization of $1.73 billion, a PE ratio of -151.33, a PEG ratio of 3.43 and a beta of 1.27. GoodRx Holdings, Inc. has a 12 month low of $4.09 and a 12 month high of $9.26. The company has a current ratio of 5.48, a quick ratio of 5.48 and a debt-to-equity ratio of 0.70.

GoodRx Profile

GoodRx Holdings, Inc, together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices.